Management After First-line Antiresorptive Treatment for Postmenopausal Osteoporosis
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Chavarry N, Abreu P, Feres-Filho E, Pereira D, Maia L, de Molon R Braz Oral Res. 2024; 38:e038.
PMID: 38747825 PMC: 11376628. DOI: 10.1590/1807-3107bor-2024.vol38.0038.
Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
Mignot M, Taisne N, Legroux I, Cortet B, Paccou J Osteoporos Int. 2017; 28(12):3431-3438.
PMID: 28875236 DOI: 10.1007/s00198-017-4215-9.